Fund News Today — September 21, 2026

Global markets are navigating a complex landscape of geopolitics and corporate developments. In the pharmaceutical sector, Novo's shares are under pressure, falling as much as 7%, despite the company's ambitious sales target of $23 billion for its blockbuster obesity drugs, including Wegovy. The Danish drugmaker is outlining its growth strategy post-Wegovy, but investors appear cautious, driving the stock down.

Beyond corporate news, geopolitical tensions continue to simmer. Russia's pro-Putin party is poised to win an election, even as the impact of the Ukraine war is felt increasingly within Russia. Meanwhile, Iranian President Pezeshkian is set to attend a UN meeting in New York, amid warnings from former US President Trump about the consequences of a potential no-deal outcome. In a separate development, the shutdown of the Saudi East-West pipeline is being closely watched by Asia's biggest crude importers, who are assessing the implications for their energy supplies. These global events are contributing to a cautious market tone, as investors weigh the potential risks and opportunities.

Today's signal:
• Novo shares slide as drugmaker lays out post-Wegovy growth strategy (cnbc.com)
• Russia’s pro-Putin party set to win election as Ukraine exposes war’s growing reach into Moscow (cnbc.com)
• Kylie Jenner sells California mansion for $5 million below asking (marketwatch.com)
• Iranian President Pezeshkian to head to New York for UN meeting as Trump warns of no-deal consequences (cnbc.com)
• Novo stock falls as much as 7% despite $23 billion sales target for blockbuster obesity drugs (cnbc.com)
• Here's what the Saudi East-West pipeline shutdown means for Asia's biggest crude importers (cnbc.com)